Literature DB >> 7021719

Quantitation of neutrophil phagocytosis, using fluorescent latex beads. Correlation of microscopy and flow cytometry.

P A Dunn, H W Tyrer.   

Abstract

Phagocytic particle uptake was calculated from data obtained by microscopy and flow cytometry utilizing commercially available fluorescent beads of uniform (2 micrometer diameter) size. PMNs collected from a Ficoll-Hypaque density gradient were incubated with the fluorescent beads in human plasma and gently washed in buffer to remove most of the extracellular beads. The cells were observed and analyzed by fluorescence microscopy (sample size = 300 cells) and flow cytometry (sample size = 50,000 cells) to determine the percent phagocytic cells, number of beads per phagocytic cell, and beads per 100 PMNs. Correlation of these indices for microscopic and machine counts was in high agreement, with r values greater than 0.80. Since flow cytometry increases the sample size 500-fold above that attained by manual microscopic counts, the coefficient of variation is proportionately reduced. Unlike other automated techniques for phagocytosis such as the use of radiolabeled particles, flow cytometry yields information on the cell population such as percent of phagocytic cells and the distribution of intracellular fluorescent beads per cell as well as particle uptake. Thus the advantages of speed, greater statistical accuracy, and the ability to accumulate information on the cell population indicate that flow cytofluorometry has unique applications for the study of phagocytosis. Application of the technique to in vitro stimulation of blood neutrophil phagocytic uptake is included.

Entities:  

Mesh:

Year:  1981        PMID: 7021719

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  23 in total

1.  Polymorphonuclear leukocyte function and serum opsonic activity in surgical patients.

Authors:  T Inoue; M Obata; Y Mishima
Journal:  Surg Today       Date:  1992       Impact factor: 2.549

2.  Flow cytometric assay for quantifying opsonophagocytosis and killing of Staphylococcus aureus by peripheral blood leukocytes.

Authors:  E Martin; S Bhakdi
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

3.  Are soluble factors relevant for polymorphonuclear leukocyte dysregulation in septicemia?

Authors:  C Wenisch; W Graninger
Journal:  Clin Diagn Lab Immunol       Date:  1995-03

4.  Prospective randomized comparison of cefodizime versus cefuroxime for perioperative prophylaxis in patients undergoing coronary artery bypass grafting.

Authors:  C Wenisch; A Bartunek; K Zedtwitz-Liebenstein; M Hiesmayr; B Parschalk; T Pernerstorfer; W Graninger
Journal:  Antimicrob Agents Chemother       Date:  1997-07       Impact factor: 5.191

5.  Activation of neutrophil function by recombinant human granulocyte colony-stimulating factor improves the survival of rats with peritonitis.

Authors:  H Ishikura; Y Uedono; K Yamagami; T Arai; N Takeyama; T Tanaka
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

Review 6.  The use of the clinical immunology laboratory.

Authors:  S H Yoshida; B C Veit; L E Mansfield; M E Gershwin
Journal:  Clin Rev Allergy       Date:  1994

7.  Flow cytometric characterization of bovine blood neutrophil phagocytosis of fluorescent bacteria and zymosan particles.

Authors:  A M Saad; M Hageltorn
Journal:  Acta Vet Scand       Date:  1985       Impact factor: 1.695

8.  Impairment of raw 264.7 macrophage function by antiarrhythmic drugs.

Authors:  K C Das; H P Misra
Journal:  Mol Cell Biochem       Date:  1994-03-30       Impact factor: 3.396

9.  Changes in complement and immunoglobulin G receptor expression on neutrophils associated with Porphyromonas gingivalis-induced inhibition of phagocytosis.

Authors:  H Tai; T Kobayashi; K Hara
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

10.  Haemorrhagic shock and encephalopathy.

Authors:  K J Van Acker; A M Roodhooft; H Van Bever
Journal:  Eur J Pediatr       Date:  1986-04       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.